1. Home
  2. GLP vs SNDX Comparison

GLP vs SNDX Comparison

Compare GLP & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLP
  • SNDX
  • Stock Information
  • Founded
  • GLP 2005
  • SNDX 2005
  • Country
  • GLP United States
  • SNDX United States
  • Employees
  • GLP N/A
  • SNDX N/A
  • Industry
  • GLP Oil Refining/Marketing
  • SNDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GLP Energy
  • SNDX Health Care
  • Exchange
  • GLP Nasdaq
  • SNDX Nasdaq
  • Market Cap
  • GLP 1.7B
  • SNDX 1.4B
  • IPO Year
  • GLP 2005
  • SNDX 2016
  • Fundamental
  • Price
  • GLP $49.06
  • SNDX $13.40
  • Analyst Decision
  • GLP Strong Buy
  • SNDX Strong Buy
  • Analyst Count
  • GLP 1
  • SNDX 11
  • Target Price
  • GLP $54.00
  • SNDX $37.64
  • AVG Volume (30 Days)
  • GLP 75.7K
  • SNDX 1.9M
  • Earning Date
  • GLP 11-08-2024
  • SNDX 11-05-2024
  • Dividend Yield
  • GLP 5.94%
  • SNDX N/A
  • EPS Growth
  • GLP N/A
  • SNDX N/A
  • EPS
  • GLP 3.31
  • SNDX N/A
  • Revenue
  • GLP $17,386,440,000.00
  • SNDX $16,000,000.00
  • Revenue This Year
  • GLP $15.01
  • SNDX N/A
  • Revenue Next Year
  • GLP $30.51
  • SNDX N/A
  • P/E Ratio
  • GLP $14.71
  • SNDX N/A
  • Revenue Growth
  • GLP 5.31
  • SNDX N/A
  • 52 Week Low
  • GLP $37.00
  • SNDX $13.26
  • 52 Week High
  • GLP $58.77
  • SNDX $25.34
  • Technical
  • Relative Strength Index (RSI)
  • GLP 35.18
  • SNDX 30.64
  • Support Level
  • GLP $52.73
  • SNDX $13.36
  • Resistance Level
  • GLP $56.61
  • SNDX $14.18
  • Average True Range (ATR)
  • GLP 2.17
  • SNDX 0.81
  • MACD
  • GLP -1.09
  • SNDX -0.18
  • Stochastic Oscillator
  • GLP 3.06
  • SNDX 11.32

About GLP Global Partners LP Common Units representing Limited Partner Interests

Global Partners LP is an U.S.-based limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

Share on Social Networks: